Choose your location
Select your country or region to view content specific to your country.
참고논문
-
Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
-
Identification of SARS-CoV-2 and Enteroviruses in Sewage Water - A Pilot Study
-
Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
-
Cycle Threshold Probability Score for Immediate and Sensitive Detection of B.1.351 SARS-CoV-2 Lineage
-
Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs
-
Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
-
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings
-
Lumipulse G SARS-CoV-2 Ag assay evaluation using clinical samples from different testing groups
-
Assay System for Simultaneous Detection of SARS-CoV-2 and Other Respiratory Viruses
-
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test
-
Validation of saliva sampling as an alternative to oro-nasopharyngeal swab for detection of SARS-CoV-2 using unextracted rRT-PCR with the Allplex 2019-nCoV assay
-
The importance of cycle threshold values in interpreting molecular tests for SARS-CoV-2
-
The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
-
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic
-
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis
-
The use of saliva as a diagnostic specimen for SARS-CoV-2 molecular diagnostic testing for pediatric patients
-
Rapid RNA extraction method for SARS-CoV-2 coronavirus (SARS-COV-2) detection from nasopharyngeal swabs
-
Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA
-
Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction
-
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic
-
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic
-
SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene
-
Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests
-
Performance of a RT-PCR assay specific for SARS-CoV-2
-
Novel SARS-CoV-2 full genome material for use in a swab-based formulation as a multi-platform NAAT quality control
-
Evaluation of Four Commercial Kits for SARS-CoV-2 Real-Time Reverse-Transcription Polymerase Chain Reaction Approved by Emergency-Use-Authorization in Korea
-
Clinical performance of a new high-throughput SARS-CoV-2 RT-PCR assay
-
The implementation of a rapid sample preparation method for the detection of SARS-CoV-2 in a diagnostic laboratory in South Africa
-
Pool-testing approach for molecular diagnostic and surveillance of SARS-CoV-2 spread
-
Evaluating the use of oropharyngeal wash for SARS-CoV-2 PCR diagnostic
제품소개
-
SARS-CoV-2 Assay
SARS-CoV-2 타겟 유전자 4종을 동시 검사하는 Multiplex real-time PCR 제품Allplex™ SARS-CoV-2 Assay는 COVID-19 원인 바이러스인 SARS-CoV-2의 타겟 유전자 4종을 1개의 튜브로 동시 검사하는 Multiplex real-time PCR 제품입니다.이 제품은 SARS-CoV-2에 특이적인 RdRP, S, N 유전자 서열과 모든 사베코바이러스 (Sarbecovirus)에 공통적인 E 유전자 서열을 한 번에 검사할 수 있어 정확도가 높으며, 자동화 플랫폼 적용으로 대용량 검사를 효율적으로 할 수 있습니다.
-
SARS-CoV-2/FluA/FluB/RSV Assay
Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay는 COVID-19 원인 바이러스인 SARS-CoV-2의 타겟 유전자 3종과 Flu A, Flu B, RSV를 1개의 튜브로 동시 구분 검사하는 Multiplex real-time PCR 제품입니다.이 제품은 SARS-CoV-2에 특이적인 RdRP, S, N 유전자 서열을 한 번에 검사할 수 있어 정확도가 높으며, Flu A, Flu B, RSV까지 동시 검사하여 대용량 검사를 효율적으로 할 수 있습니다.
뉴스 & 미디어
영상 클립
-
Event
Seegene announces ‘$12 PCR Testing’ initiative to help end COVID-19 pandemic
May 31, 2022
-
Event
Introducing the Workflow of Seegene Allplex™ SARS-CoV-2 fast PCR Assay
Feb 18, 2022
-
Event
Seegene Omicron Response: Q&A Session with Dr. Yun-Jee Kim
Dec 07, 2021
-
Event
How Seegene is Responding to Omicron
Dec 01, 2021
-
Event
Screening and Identification of SARS-CoV-2&Variants
Apr 01, 2021
뉴스
-
제품 뉴스
Novaplex™ SARS-CoV-2 Variants VII Assay 출시
Dec 20, 2021
-
제품 뉴스
Allplex™ SARS-CoV-2 Variants II Assay CE-IVD 인증 획득
Jun 30, 2021
-
제품 뉴스
Allplex™ SARS-CoV-2 Master Assay CE-IVD 인증 획득
Mar 26, 2021
-
제품 뉴스
Allplex™ SARS-CoV-2 Variants I Assay CE-IVD 인증 획득
Mar 26, 2021
-
제품 뉴스
식품의약품안전처 (MFDS) 허가 완료 – 코로나19∙인플루엔자∙RSV 바이러스 Primary screening 동시 검사 제품, Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay
Jan 26, 2021
-
제품 뉴스
식품의약품안전처 (MFDS) 허가 완료 – 코로나19 감염증 검사제품, Allplex™ SARS-CoV-2 Assay
Dec 07, 2020
-
제품 뉴스
Allplex™ SARS-CoV-2/Flu A/Flu B/RSV Assay CE-IVD 인증 획득
Sep 15, 2020
